Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Fluticasone furoate / Vilanterol bulk supplier for pharma manufacturers

Fluticasone Furoate / Vilanterol Suppliers & Bulk Manufacturers

Available Forms: Powder For Inhalation(DPI/MDI)

Available Strengths: 92 mcg Fluticasone furoate / 22 mcg Vilanterol; 184 mcg Fluticasone furoate / 22 mcg Vilanterol

Reference Brands: Breo Ellipta®(US), Relvar Ellipta® (EU)

Category: Respiratory Disorder

Fluticasone furoate + Vilanterol, sold as Breo Ellipta® (U.S.) and Relvar Ellipta® (EU), is a once-daily inhalation therapy for asthma and COPD. It combines anti-inflammatory and bronchodilator action in strengths like 92/22 mcg and 184/22 mcg, delivered via the Ellipta® DPI. A top choice in respiratory care and pharma exports.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

Fluticasone furoate and Vilanterol is a powerful once-daily combination therapy used for the long-term treatment of asthma and chronic obstructive pulmonary disease (COPD). Marketed as Breo Ellipta® in the U.S. and Relvar Ellipta® in the EU, this inhalation powder combines Fluticasone, a corticosteroid that reduces inflammation, with Vilanterol, a long-acting beta-agonist (LABA) that relaxes airway muscles. Available in 92/22 mcg and 184/22 mcg strengths via the Ellipta® DPI, it offers 24-hour symptom control. Ideal for pharma B2B and export markets, this therapy enhances adherence and delivers effective respiratory relief with convenient once-daily dosing.

Fluticasone Furoate / Vilanterol — third party manufacturing & bulk supply

Fluticasone Furoate / Vilanterol is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Manufacturers of Fluticasone Furoate / Vilanterol listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Fluticasone Furoate / Vilanterol →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Fluticasone furoate / vilanterol is used for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). It helps reduce airway inflammation, improve lung function, and prevent symptoms such as wheezing, breathlessness, and exacerbations.

This combination is made from fluticasone furoate and vilanterol trifenatate. Fluticasone furoate is a corticosteroid that reduces inflammation in the airways, while vilanterol is a long-acting beta-2 agonist (LABA) that provides prolonged bronchodilation.

Common trade names include Breo Ellipta (USA), Relvar Ellipta (EU/UK), and various regional brands in global markets.

The original product is developed and marketed by GlaxoSmithKline (GSK) in collaboration with Innoviva. It is also manufactured by other pharmaceutical companies as per regional approvals.

The complete generic name is fluticasone furoate and vilanterol trifenatate.

Brand names include Breo Ellipta and Relvar Ellipta.

This inhalation product is manufactured globally in countries such as the USA, UK, EU nations, and other regions by innovator pharmaceutical companies and approved manufacturers.

Related Products

Salmeterol Xinafoate

Strength:
25 µg, 50 µg

Form: Inhalation

Reference Brands: Serevent (USA/LATAM/EU)

View Details
Formoterol Fumarate

Strength:
12 µg

Form: Inhalation

Reference Brands: Foradil (USA/LATAM), Oxis (India)

View Details
Ethionamide

Strength:
250 mg

Form: Tablets

Reference Brands: Generic formulations marketed under different names

View Details
Olodaterol

Strength:
2.5 mcg

Form: Inhalation solution

Reference Brands: Striverdi Respimat (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.